A First In-Human, Phase I/II Study of CFI-402411, Hematopoietic Progenitor Inase-1 (HPK1) Inhibitor, As A Single Agent and In Combination With Pembrolizumab In Subjects With Advanced Solid Malignancies
A First In-Human, Phase I/II Study of CFI-402411, Hematopoietic Progenitor Inase-1 (HPK1) Inhibitor, As A Single Agent and In Combination With Pembrolizumab In Subjects With Advanced Solid Malignancies